VERSANIS
DEAD

Serial Number

90555614

Owner

VERSANIS BIO, INC.

Filing Date

Mar 2, 2021

Add to watchlist:

No watchlists yet
View on USPTO

VERSANIS Trademark

Serial Number: 90555614

VERSANIS is a trademark filed by VERSANIS BIO, INC. on March 2, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

VERSANIS BIO, INC. (4 trademarks)

Lilly Corporate Center
Indianapolis, IN 46285

Entity Type: 03

Libra Bio, Inc. (2 trademarks)

Suite 1300
Oakland, CA 94607

Entity Type: 03

Trademark Details

Filing Date

March 2, 2021

Registration Date

Not Registered

Published for Opposition

November 2, 2021

Goods & Services

Pharmaceutical preparations for prevention and treatment of diseases, disorders, and degenerative conditions associated with aging; Pharmaceutical preparations for the diagnosis, prevention and treatment of chronic diseases, conditions and functional disorders; Pharmaceutical preparations for diagnosis, prevention and treatment of diseases by gene therapy; neutraceuticals and cosmeceuticals that mitigate aging, treat immunological diseases and degenerative conditions of the body, promote life extension, and restore bodily functions; syringes, vials or pumps sold filled with pharmaceutical preparations for prevention and treatment of diseases, disorders, and degenerative conditions associated with aging

Medical diagnostics services; medical services for the diagnosis of diseases, disorders and degenerative conditions associated with aging; providing information in the field of medical diagnostics; providing information relating to diagnosis and monitoring of chronic diseases, conditions and functional disorders; providing medical information and news in the field of diseases, disorders, and degenerative conditions associated with aging

Research and development services in the field of diseases, disorders, and degenerative conditions associated with aging; Research and development services in the fields of chronic diseases, conditions and functional disorders; Scientific research services in the field of gene therapy

Filing History

ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
May 31, 2024 MAB5
ABANDONMENT - AFTER PUBLICATION
May 31, 2024 ABN5
TEAS EXPRESS ABANDONMENT RECEIVED
May 30, 2024 EXAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 9, 2023 EXRA
SOU EXTENSION 4 GRANTED
Nov 7, 2023 EX4G
SOU EXTENSION 4 FILED
Nov 7, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
Nov 7, 2023 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 29, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 29, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 29, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 29, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 29, 2023 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 29, 2023 EXRA
SOU EXTENSION 3 GRANTED
Jun 27, 2023 EX3G
SOU EXTENSION 3 FILED
Jun 27, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 27, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 21, 2022 EXRA
SOU EXTENSION 2 GRANTED
Dec 19, 2022 EX2G
SOU EXTENSION 2 FILED
Dec 19, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 19, 2022 EEXT
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 27, 2022 ASGN
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 12, 2022 EXRA
SOU EXTENSION 1 GRANTED
Jul 11, 2022 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 11, 2022 AITU
SOU EXTENSION 1 FILED
Jun 27, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 27, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 28, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 2, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 2, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 13, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 24, 2021 CNSA
ASSIGNED TO EXAMINER
Sep 23, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 3, 2021 NWOS
NEW APPLICATION ENTERED
Mar 5, 2021 NWAP